Speaker Bios
Prof. Caroline Wagner is an assistant professor in the department of Bioengineering at McGill University. She received her B. Eng from McGill, and her M.Sc. and PhD in Mechanical Engineering from the Massachusetts Institute of Technology (MIT). Her research program focuses on understanding the interaction between pathogens and biological fluids, and modeling the effect of such interactions on population-level disease dynamics. During the Covid-19 pandemic, she has worked on mathematical simulations for future burden and timing of Covid-19 infections given different assumptions related to adaptive immune responses arising from vaccines and natural infections.
Prof. David Juncker is a professor and the Chair of the Biomedical Engineering department at McGill university. He received his Diploma (European Master equivalent, 1995) and PhD (2002) from the Institute of Microtechnology (now part of EPFL) of the University of Neuchâtel. He then conducted his post-doc at the IBM Zurich Research Laboratory and the Swiss Federal Institute of Technology in Zurich (ETH). His lab is exploring various facets of miniaturization and integration in biology and medicine, which includes the conception, engineering and utilization of novel micro and nanotechnologies for manipulating, stimulating and studying oligonucleotides, proteins, cells, and tissues.
Prof. Donald Sheppard is a professor at McGill University and Chair for the Department of Microbiology & Immunology. His laboratory is involved in identifying the molecular mechanisms whereby pathogenic fungi cause human disease. His lab focuses on two pathogens, Candida albicans and Aspergillus fumigatus, both of which cause fatal infections in immunocompromised hosts. The adherence of these organisms to host tissues, especially vascular endothelial cells is a critical step in the pathogenesis of infection, and our work has begun to elucidate the fungal adhesins involved in this process and the genetic pathways controlling their expression.
Marc Saab is the founder and managing director of BML technology. BML Technology is a digital health services firm in Montreal, focused on the adoption of digital health technology in value-based healthcare and precision medicine. He is a talented and passionate business leader with 20 years’ experience in Medical Device, Digital Health and Consumer Wearable markets. He has expertise in all aspects of medical device and wearable product development from conception R&D to launch and commercialization for international markets, including regulatory compliance and strategic business development. He is also a Biomedical Engineer with a Master’s Degree in neurological (EEG) signal processing from McGill University Biomedical Engineering.